RUNX1 and colorectal cancer: For example, RUNX1 activation in colorectal cancer correlated with various possible mechanisms, including the Wnt/β-catenin signaling pathway [9] and TGF-β induction through the Smad-dependent pathway and Smad-independent pathway [10].